Save the Date for Applied Pharmaceutical Analysis 2019!

September 9-11, 2019

Revere Hotel Boston Common 
200 Stuart Street 
Boston, MA 02116

APA 2019 Plenary Speakers 

		Paula Annunziato, MD, Vice President and Therapeutic Head, Vaccines Clinical Research, Merck Vaccine Development - Title TBA				Samir M. Hanash, MD, PhD, Professor, Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center Title TBA
		Nina Isoherranen, PhD, Professor, Vice Chair, Pharmaceutics, Department of Pharmaceutics, University of Washington Predicting in vivo Drug–Drug Interactions Involving Multiple Precipitants				Irina Koroleva, PhD, Director, Translational Medicine, Rubius Therapeutics Title TBA

APA 2019 Confirmed Speakers

Arjun Arumugam, M.D., Executive Director, Azidus Laboratories Limited

Mark Dysinger, Development Scientist, Bioanalytical Development, Alexion Pharmaceuticals

Mireia Fernandez Ocana, Ph.D., Global Biomarker Discovery Lead, Drug Safety (Assoc. Dir.), Pfizer

Jaya Goyal, Ph.D., Vice President, Bioanalytical, Pharmacology and Biomarker Development, Wave Life Sciences Ltd.

Huidong Gu, Senior Research Scientist II, Bristol-Myers Squibb

Hyunyoung (Young) Jeong, Ph.D., Professor, University of Illinois at Chicago

John Kadavil, Ph.D.,Deputy Director, CDER/OTS/OSIS/DGDBE, U.S. Food and Drug Administration

Amit Kalgutkar, Ph.D., Research Fellow, Pfizer

Colleen Kelly, M.D., Assistant Professor of Medicine, The Warren Alpert Medical School, Brown University

Jean-Claude Marshall, Ph.D., Head of Clinical Biomarker Technologies, Pfizer

Mark Milton, Ph.D., Ophthalmology Therapeutic Area Head, PK Sciences, Novartis Institutes for BioMedical Research (NIBR)

Kaushik Mitra, Ph.D., Director, Molecular and Investigative Toxicology, Merck

Leila Pirhaji, Ph.D., Founder and CEO, ReviveMed

Brooke Rock, Ph.D., Principal Scientist at Amgen

Michael Skelly, Ph.D., Lead Pharmacologist, CDER/OTS/OSIS, U.S. Food and Drug Administration

Yu Tian, Ph.D., Director, AbbVie

Esther van Duijn, Ph.D., Scientist, TNO (Netherlands Organisation for Applied Scientific Research)

Sheri Wilcox, Senior Director, SomaLogic

Fan Wu, Senior Principal Scientist, Celgene Corporation

Yuching Yang, Ph.D., Clinical Pharmacometrics Reviewer, U.S. Food and Drug Administration

Sessions for APA 2019 Workshops 

Regulated Bioanalysis

FDA/Regulatory Session

Digital State of Regulated Bioanalysis

Bioanalytical Support of Novel Therapies and New Modalities in Clinical Development

Implementation of 2018 FDA BMV Guidance/ICH M10

Frontiers of Biomarker Bioanalysis

Discovery Bioanalysis and New Technologies

Novel modalities, guidance for new modalities

Cellular and Gene Therapies

Omics

Advanced LC-MS and Applications of HRMS

AI Session - Predict the Structure

Mechanistic ADME

Not Your Average Human ADME Study

Toxicity and Drug Metabolism: Advances in the Mechanistic Understanding that Inform Risk Management

Improved Clinical Outcomes Through Modeling

Insights and Development Challenges of New Modalities

From Accidents to Innovation: Serendipity in Drug Discovery

Expanding Horizons - Beyond Mechanistic ADME and Bioanalysis Workshop (NASH/Fibrosis/Microbiome)

APA 2018 Conference Program